To verify that p38-MAPK signaling is also active in primary human LPSCs, we incubated CD34+ LSPCs from 3 newly diagnosed patients with AML (Table S2) in the presence and absence of rh-IL-21 and performed bulk RNA-seq. The gene discussed is CD34; the disease is acute myeloid leukemia.